AGREEMENT AND PLAN OF MERGER By and Among BRISTOL-MYERS SQUIBB COMPANY, GOTHAM MERGER SUB INC. and MYOKARDIA, INC. Dated as of October 3, 2020Merger Agreement • October 5th, 2020 • MyoKardia, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 5th, 2020 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated as of October 3, 2020 (this “Agreement”), is by and among Bristol-Myers Squibb Company, a Delaware corporation (“Parent”), Gotham Merger Sub Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and MyoKardia, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 8.12.